What Healthcare Professionals Should Know About the Bundibugyo Ebola Outbreak
Share this article
On May 17, the World Health Organization (WHO) declared the Ebola outbreak caused by the Bundibugyo virus in the Democratic Republic of the Congo (DRC) and Uganda a Public Health Emergency of International Concern (PHEIC), reflecting growing concerns about the scale and complexity of the outbreak.
As of May 17, health officials have reported:
- DRC: 10 laboratory-confirmed Ebola cases and approximately 395 suspected cases, including 106 associated deaths
- Uganda: 2 laboratory-confirmed cases, including 1 death, in individuals who had recently traveled from the DRC
Public health experts warn the outbreak may be significantly larger than current numbers suggest. Concerns are being driven by increasing reports of suspected cases and evidence of cross-border spread into Uganda.
Understanding the Bundibugyo Virus
The Bundibugyo virus is one of several species of Ebola virus known to cause Ebola disease. Unlike some other Ebola virus species, there are currently no approved vaccines or targeted treatments specifically for Bundibugyo virus disease (BVD).
However, experts emphasize that early recognition, supportive clinical care, and rapid implementation of infection prevention and control measures can significantly improve survival.
What Healthcare Professionals Should Know
Healthcare facilities and frontline personnel should stay informed on the evolving epidemiology of the outbreak, including geographic spread, exposure risks, incubation periods, early symptoms, and recommended infection prevention and control measures.
Geographic Spread and Exposure Risks
The outbreak has involved transmission in both the DRC and Uganda, with cases linked through cross-border travel. Exposure risk is highest through direct contact with:
- Blood or body fluids of infected individuals
- Contaminated materials or surfaces
- Blood or secretions of infected wildlife
Healthcare settings remain especially vulnerable when infection prevention protocols are not strictly practiced.
Incubation Period
The incubation period for BVD ranges from 2 to 21 days, and individuals are usually not infectious until symptoms begin.
Early Signs and Symptoms
Early symptoms of BVD may resemble other infectious illnesses and can include:
- Fever
- Fatigue
- Headache
- Muscle pain
- Sore throat
As illness progresses, patients may develop:
- Vomiting and diarrhea
- Abdominal pain
- Rash
- Unexplained bleeding or bruising
- Multi-organ dysfunction in severe cases
Early identification remains critical for reducing transmission risk and improving outcomes.
Preparedness Remains Essential
Although the risk of widespread transmission in the United States remains low, healthcare facilities should continue reinforcing preparedness activities and maintaining staff readiness for high-consequence infectious diseases (HCIDs).
NETEC encourages healthcare facilities to:
- Stay informed on evolving epidemiology and outbreak updates
- Review and reinforce infection prevention and control practices
- Ensure staff training and PPE competencies remain current
- Maintain screening and triage protocols
- Continue applying the “Identify, Isolate, Inform” (III) strategy
The III approach remains a cornerstone of HCID preparedness:
- Identify patients with compatible symptoms and exposure history
- Isolate suspected patients promptly and safely
- Inform infection prevention teams, leadership, and public health authorities
Training and Preparedness Resources
NETEC’s Ebola resource exhibit provides healthcare facilities and frontline personnel with training materials and preparedness resources related to:
- Ebola virus disease
- Staff training and education
- Hospital preparedness
- Infection prevention and control
- Identify, Isolate, Inform (III) strategies
Explore the exhibit here:
https://repository.netecweb.org/exhibits/show/ebola2021/ebola